CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,424,000 | +83.1% | 186,900 | -1.1% | 0.00% | +200.0% |
| Q2 2022 | $1,324,000 | -15.5% | 188,911 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,566,000 | +22.1% | 188,911 | -0.3% | 0.00% | 0.0% |
| Q4 2021 | $1,283,000 | +13.6% | 189,511 | -11.0% | 0.00% | 0.0% |
| Q3 2021 | $1,129,000 | -6.8% | 213,006 | +1.0% | 0.00% | 0.0% |
| Q2 2021 | $1,212,000 | +109.3% | 210,806 | +67.9% | 0.00% | 0.0% |
| Q1 2021 | $579,000 | +28.4% | 125,590 | -6.9% | 0.00% | 0.0% |
| Q4 2020 | $451,000 | +12.5% | 134,827 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $401,000 | +281.9% | 134,827 | +492.5% | 0.00% | – |
| Q2 2020 | $105,000 | +1212.5% | 22,754 | +983.5% | 0.00% | – |
| Q4 2017 | $8,000 | – | 2,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |